GeoVax Labs, Inc. SEC filings GOVX
GeoVax Labs, Inc. has 1,000 filings in SEC EDGAR's recent list, going back to Aug 5, 2008. Its latest annual report, Form 10-K, was filed on Apr 15, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Jul 27, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 27, 2026 (shareholder vote results). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| DEF 14A | Proxy statement | Sep 10, 2026 | Oct 27, 2026 |
| PRE 14A | Preliminary proxy statement | Aug 31, 2026 | Oct 27, 2026 |
| DEF 14A | Proxy statement | Apr 27, 2026 | Jun 17, 2026 |
| PRE 14A | Preliminary proxy statement | Apr 16, 2026 | Jun 17, 2026 |
| DEF 14A | Proxy statement | Oct 14, 2025 | Nov 26, 2025 |
| PRE 14A | Preliminary proxy statement | Oct 3, 2025 | Nov 26, 2025 |
| DEF 14A | Proxy statement | Apr 14, 2025 | Jun 5, 2025 |
| PRE 14A | Preliminary proxy statement | Mar 28, 2025 | Jun 5, 2025 |
| DEF 14A | Proxy statement | Aug 1, 2024 | Sep 17, 2024 |
| PRE 14A | Preliminary proxy statement | Jul 22, 2024 | Sep 17, 2024 |
| DEF 14A | Proxy statement | Apr 15, 2024 | May 23, 2024 |
| PRE 14A | Preliminary proxy statement | Apr 3, 2024 | May 23, 2024 |
| DEF 14A | Proxy statement | Nov 27, 2023 | Jan 16, 2024 |
| PRE 14A | Preliminary proxy statement | Nov 17, 2023 | Jan 16, 2024 |
| DEF 14A | Proxy statement | Jun 12, 2023 | Aug 1, 2023 |
| DEF 14A | Proxy statement | Jun 13, 2022 | Aug 3, 2022 |
| PRE 14A | Preliminary proxy statement | May 27, 2022 | Aug 3, 2022 |
| DEF 14A | Proxy statement | Jun 21, 2021 | Aug 11, 2021 |
| DEFA14A | Additional proxy material | Jul 28, 2020 | — |
| DEFA14A | Additional proxy material | Jul 7, 2020 | — |
| DEF 14A | Proxy statement | Jul 7, 2020 | Aug 7, 2020 |
| PRE 14A | Preliminary proxy statement | Jun 26, 2020 | Aug 7, 2020 |
| DEF 14A | Proxy statement | Dec 2, 2019 | Jan 3, 2020 |
| PRE 14A | Preliminary proxy statement | Nov 21, 2019 | Jan 3, 2020 |
| DEFA14A | Additional proxy material | Mar 14, 2019 | — |
| DEFA14A | Additional proxy material | Mar 14, 2019 | — |
| DEF 14A | Proxy statement | Mar 1, 2019 | Apr 15, 2019 |
| PRE 14A | Preliminary proxy statement | Feb 19, 2019 | Apr 15, 2019 |
| DEFA14A | Additional proxy material | Apr 27, 2018 | — |
| DEF 14A | Proxy statement | Apr 27, 2018 | Jun 14, 2018 |
| DEF 14A | Proxy statement | Jun 16, 2017 | Aug 4, 2017 |
| PRE 14A | Preliminary proxy statement | Jun 6, 2017 | Aug 4, 2017 |
| DEF 14A | Proxy statement | Apr 26, 2017 | Jun 5, 2017 |
| DEF 14A | Proxy statement | Apr 29, 2016 | Jun 14, 2016 |
| PRE 14A | Preliminary proxy statement | Apr 15, 2016 | Jun 14, 2016 |
| DEF 14A | Proxy statement | Mar 31, 2015 | May 12, 2015 |
| PRE 14A | Preliminary proxy statement | Mar 20, 2015 | May 12, 2015 |
| DEFA14A | Additional proxy material | Apr 30, 2014 | — |
| DEF 14A | Proxy statement | Apr 30, 2014 | Jul 1, 2014 |
| DEF 14A | Proxy statement | Apr 23, 2013 | Jun 10, 2013 |
| PRE 14A | Preliminary proxy statement | Apr 12, 2013 | Jun 10, 2013 |
| DEFA14A | Additional proxy material | Apr 26, 2012 | — |
| DEF 14A | Proxy statement | Apr 26, 2012 | Jun 21, 2012 |
| PRE 14A | Preliminary proxy statement | Apr 16, 2012 | Jun 21, 2012 |
| DEFA14A | Additional proxy material | Jul 6, 2011 | — |
| DEF 14A | Proxy statement | Jul 6, 2011 | Aug 16, 2011 |
| DEFA14A | Additional proxy material | Jul 9, 2010 | — |
| DEF 14A | Proxy statement | Jul 9, 2010 | Aug 24, 2010 |
| DEF 14A | Proxy statement | Mar 12, 2010 | Apr 13, 2010 |
| PRE 14A | Preliminary proxy statement | Feb 26, 2010 | Apr 13, 2010 |
| DEFA14A | Additional proxy material | Apr 29, 2009 | — |
| DEF 14A | Proxy statement | Apr 29, 2009 | Jun 18, 2009 |
Showing 52 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- GOVX (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Smyrna, GA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 832489
- Former names
- DAUPHIN TECHNOLOGY INC (until Sep 20, 2006)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.